Annual Cash & Cash Equivalents
$22.54 M
+$12.56 M+125.87%
December 31, 2023
Summary
- As of February 7, 2025, ATYR annual cash & cash equivalents is $22.54 million, with the most recent change of +$12.56 million (+125.87%) on December 31, 2023.
- During the last 3 years, ATYR annual cash & cash equivalents has risen by +$5.59 million (+32.99%).
- ATYR annual cash & cash equivalents is now -57.48% below its all-time high of $53.02 million, reached on December 1, 2015.
Performance
ATYR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$11.46 M
+$4.65 M+68.38%
September 1, 2024
Summary
- As of February 7, 2025, ATYR quarterly cash and cash equivalents is $11.46 million, with the most recent change of +$4.65 million (+68.38%) on September 1, 2024.
- Over the past year, ATYR quarterly cash and cash equivalents has increased by +$4.65 million (+68.38%).
- ATYR quarterly cash and cash equivalents is now -81.83% below its all-time high of $63.07 million, reached on June 1, 2015.
Performance
ATYR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ATYR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +125.9% | +68.4% |
| 3 y3 years | +33.0% | +14.8% |
| 5 y5 years | -1.8% | +14.8% |
ATYR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +865.1% | -49.2% | +390.5% |
| 5 y | 5-year | at high | +865.1% | -80.8% | +422.7% |
| alltime | all time | -57.5% | +865.1% | -81.8% | +422.7% |
ATyr Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.46 M(+68.4%) |
| Jun 2024 | - | $6.80 M(-0.0%) |
| Mar 2024 | - | $6.81 M(-69.8%) |
| Dec 2023 | $22.54 M(+125.9%) | $22.54 M(+130.3%) |
| Sep 2023 | - | $9.79 M(-20.5%) |
| Jun 2023 | - | $12.31 M(-40.5%) |
| Mar 2023 | - | $20.69 M(+107.3%) |
| Dec 2022 | $9.98 M(+327.3%) | - |
| Dec 2022 | - | $9.98 M(-45.6%) |
| Sep 2022 | - | $18.36 M(+116.4%) |
| Jun 2022 | - | $8.48 M(+1.9%) |
| Mar 2022 | - | $8.32 M(+256.3%) |
| Dec 2021 | $2.34 M(-86.2%) | $2.34 M(-96.1%) |
| Sep 2021 | - | $59.74 M(+2625.5%) |
| Jun 2021 | - | $2.19 M(-82.6%) |
| Mar 2021 | - | $12.59 M(-25.7%) |
| Dec 2020 | $16.95 M(+84.1%) | $16.95 M(-6.6%) |
| Sep 2020 | - | $18.15 M(-16.1%) |
| Jun 2020 | - | $21.63 M(-45.2%) |
| Mar 2020 | - | $39.45 M(+328.4%) |
| Dec 2019 | $9.21 M | $9.21 M(-46.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $17.34 M(+19.5%) |
| Jun 2019 | - | $14.51 M(+11.9%) |
| Mar 2019 | - | $12.96 M(-43.5%) |
| Dec 2018 | $22.96 M(+8.9%) | $22.96 M(-27.2%) |
| Sep 2018 | - | $31.55 M(+63.7%) |
| Jun 2018 | - | $19.27 M(-12.1%) |
| Mar 2018 | - | $21.94 M(+4.0%) |
| Dec 2017 | $21.09 M(-45.1%) | $21.09 M(-29.1%) |
| Sep 2017 | - | $29.77 M(-17.1%) |
| Jun 2017 | - | $35.91 M(+24.3%) |
| Mar 2017 | - | $28.90 M(-24.7%) |
| Dec 2016 | $38.39 M(-27.6%) | $38.39 M(+11.8%) |
| Sep 2016 | - | $34.33 M(-20.5%) |
| Jun 2016 | - | $43.19 M(-20.2%) |
| Mar 2016 | - | $54.10 M(+2.0%) |
| Dec 2015 | $53.02 M(+281.5%) | $53.02 M(-11.7%) |
| Sep 2015 | - | $60.05 M(-4.8%) |
| Jun 2015 | - | $63.07 M(+15.7%) |
| Mar 2015 | - | $54.51 M(+292.2%) |
| Dec 2014 | $13.90 M(-61.9%) | $13.90 M |
| Dec 2013 | $36.46 M | - |
FAQ
- What is aTyr Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for aTyr Pharma?
- What is aTyr Pharma annual cash & cash equivalents year-on-year change?
- What is aTyr Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for aTyr Pharma?
- What is aTyr Pharma quarterly cash and cash equivalents year-on-year change?
What is aTyr Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of ATYR is $22.54 M
What is the all time high annual cash & cash equivalents for aTyr Pharma?
aTyr Pharma all-time high annual cash & cash equivalents is $53.02 M
What is aTyr Pharma annual cash & cash equivalents year-on-year change?
Over the past year, ATYR annual cash & cash equivalents has changed by +$12.56 M (+125.87%)
What is aTyr Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ATYR is $11.46 M
What is the all time high quarterly cash and cash equivalents for aTyr Pharma?
aTyr Pharma all-time high quarterly cash and cash equivalents is $63.07 M
What is aTyr Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, ATYR quarterly cash and cash equivalents has changed by +$4.65 M (+68.38%)